Silence Therapeutics plc (SLNCF)
OTCMKTS
· Delayed Price · Currency is USD
1.685
0.00 (0.00%)
Aug 12, 2025, 8:00 PM EDT
Silence Therapeutics Market Cap
Silence Therapeutics has a market cap or net worth of $276.32 million as of August 14, 2025. Its market cap has decreased by -71.23% in one year.
Market Cap
276.32M
Enterprise Value
162.16M
Revenue
27.17M
Ranking
n/a
PE Ratio
n/a
Stock Price
$1.69
Market Cap Chart
Since September 8, 2020, Silence Therapeutics's market cap has decreased from 538.37M to 276.32M, a decrease of -48.68%. That is a compound annual growth rate of -12.65%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 13, 2025 | 276.32M | -14.94% |
Dec 31, 2024 | 324.84M | -51.64% |
Dec 29, 2023 | 671.70M | 22.71% |
Dec 30, 2022 | 547.37M | -23.44% |
Dec 31, 2021 | 714.99M | 17.04% |
Dec 31, 2020 | 610.91M | 13.47% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Nika Pharmaceuticals | 972.72M |
Veradigm | 789.71M |
Tian'an Technology Group | 628.15M |
Elite Pharmaceuticals | 608.19M |
Glass House Brands | 543.74M |
American Oncology Network | 393.37M |
Northwest Biotherapeutics | 332.06M |
CytoDyn | 300.87M |